aTyr Pharma: (results Of Operations And Financial Condition) And Under Item 9.01 (financial Statements And Exhibits). However, Due To Administrative Error, The Submission Header Coding Of The Original Report Was Incorrectly Tagged On The Sec’s Edgar System As Item 2.06 (material Impairments) And Item 9.01 (financial Statements And Exhibits). The Sole Purpose Of This Amendment Is To Correct The Submission Header Coding And Refurnish The Original Report To Be Tagged On The Sec’s Edgar System As Item 2.02 (results Of Operations And Financial Condition) And Under Item 9.01 (financial Statements And Exhibits). No Disclosure In The Text Of The Original Report, Which Is Reproduced Below In Its Entirety, Was Changed As A Result Of This Amendment, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  aTyr Pharma Inc
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***